$CDLX
Cardlytics, Inc. Stock $cdlx

$cdlx Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000166607122000134 Filed on November 01, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$82.50M	$72.71M
YoY Change	-8.38%	11.88%
Cost Of Revenue	$38.60M	$37.56M
YoY Change	-16.92%	10.19%
Gross Profit	$43.91M	$35.14M
YoY Change	0.73%	13.75%
Gross Profit Margin	53.22%	48.34%
Selling, General & Admin	$39.77M	$38.26M
YoY Change	-5.33%	3.95%
% of Gross Profit	90.58%	108.87%
Research & Development	$12.30M	$13.76M
YoY Change	6.86%	23.53%
% of Gross Profit	28.02%	39.16%
Depreciation & Amortization	$6.849M	$10.47M
YoY Change	-28.64%	24.99%
% of Gross Profit	15.6%	29.79%
Operating Expenses	$48.81M	$52.02M
YoY Change	-14.0%	8.5%
Operating Profit	-$4.901M	$11.52M
YoY Change	-62.77%	-128.95%
Interest Expense	$4.356M	-$5.253M
YoY Change	-232.4%	10.92%
% of Operating Profit		-45.6%
Other Income/Expense, Net		-$5.253M
YoY Change		10.92%
Pretax Income	-$378.3M	$6.267M
YoY Change	1820.3%	-114.07%
Income Tax	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$378.3M	$6.267M
YoY Change	3096.27%	-114.07%
Net Earnings / Revenue	-458.5%	8.62%
Basic Earnings Per Share		$0.19
Diluted Earnings Per Share	-$11.36	$0.19
COMMON SHARES
Basic Shares Outstanding	33.17M shares	32.89M shares
Diluted Shares Outstanding		33.27M shares

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$121.9M	$138.5M
YoY Change	-47.78%	-41.65%
Cash & Equivalents	$121.9M	$138.5M
Short-Term Investments
Other Short-Term Assets	$8.058M	$8.771M
YoY Change	-0.22%	11.46%
Inventory
Prepaid Expenses
Receivables	$115.6M	$97.17M
Other Receivables	$4.470M	$4.675M
Total Short-Term Assets	$250.0M	$249.1M
YoY Change	-30.3%	-25.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.916M	$7.103M
YoY Change	-47.52%	-42.56%
Goodwill	$352.7M	$665.8M
YoY Change	-52.5%	-7.39%
Intangibles	$53.48M	$113.9M
YoY Change	-57.41%	-12.87%
Long-Term Investments
YoY Change
Other Assets	$2.586M	$2.737M
YoY Change	7.48%	6.79%
Total Long-Term Assets	$441.2M	$817.2M
YoY Change	-51.25%	-8.08%
TOTAL ASSETS
Total Short-Term Assets	$250.0M	$249.1M
Total Long-Term Assets	$441.2M	$817.2M
Total Assets	$691.2M	$1.066B
YoY Change	-45.3%	-12.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.765M	$4.768M
YoY Change	-18.49%	25.28%
Accrued Expenses	$21.34M	$20.56M
YoY Change	8.74%	239.54%
Deferred Revenue	$1.751M	$3.004M
YoY Change	-46.62%	14.35%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$38.00K	$37.00K
YoY Change	5.56%	5.71%
Total Short-Term Liabilities	$248.9M	$254.9M
YoY Change	-23.95%	-7.12%
LONG-TERM LIABILITIES
Long-Term Debt	$226.1M	$225.7M
YoY Change	22.55%	24.15%
Other Long-Term Liabilities	$0.00	$21.00K
YoY Change	-100.0%	-96.91%
Total Long-Term Liabilities	$0.00	$21.00K
YoY Change	-100.0%	-96.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$248.9M	$254.9M
Total Long-Term Liabilities	$0.00	$21.00K
Total Liabilities	$479.6M	$485.8M
YoY Change	-16.31%	-9.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$976.6M	-$598.3M
YoY Change	86.86%	17.13%
Common Stock	$1.183B	$1.169B
YoY Change	-2.49%	-2.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$211.6M	$580.5M
YoY Change
Total Liabilities & Shareholders Equity	$691.2M	$1.066B
YoY Change	-45.3%	-12.92%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$378.3M	$6.267M
YoY Change	3096.27%	-114.07%
Depreciation, Depletion And Amortization	$6.849M	$10.47M
YoY Change	-28.64%	24.99%
Cash From Operating Activities	-$13.10M	-$14.43M
YoY Change	2260.54%	38.02%
INVESTING ACTIVITIES
Capital Expenditures	$3.153M	-$3.304M
YoY Change	-192.36%	15.08%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$3.153M	-$3.304M
YoY Change	-7.64%	15.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-179.0K	-6.000K
YoY Change	-179.56%	-101.62%
NET CHANGE
Cash From Operating Activities	-13.10M	-14.43M
Cash From Investing Activities	-3.153M	-3.304M
Cash From Financing Activities	-179.0K	-6.000K
Net Change In Cash	-16.43M	-17.74M
YoY Change	338.92%	36.92%
FREE CASH FLOW
Cash From Operating Activities	-$13.10M	-$14.43M
Capital Expenditures	$3.153M	-$3.304M
Free Cash Flow	-$16.25M	-$11.13M
YoY Change	-668.52%	46.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001666071
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38386
	dei	Entity Registrant Name EntityRegistrantName	CARDLYTICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3039436
	dei	Entity Address Address Line1 EntityAddressAddressLine1	675 Ponce de Leon Ave. NE, Ste 6000
	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30308
	dei	City Area Code CityAreaCode	(888)
	dei	Local Phone Number LocalPhoneNumber	792-5802
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	CDLX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33165847	shares
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	233467000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	138514000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	95000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	8500000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	74000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	111085000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	97168000	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6097000	usd
CY2022Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	4675000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7981000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8697000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	358725000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	249128000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11273000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7103000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10196000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9276000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	125550000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	113878000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	742516000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	665813000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	13131000	usd
CY2022Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	18377000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2406000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2737000	usd
CY2021Q4	us-gaap	Assets Assets	1263797000	usd
CY2022Q3	us-gaap	Assets Assets	1066312000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4619000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4768000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12136000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12940000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19620000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20556000	usd
CY2021Q4	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	46595000	usd
CY2022Q3	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	41051000	usd
CY2021Q4	cdlx	Customer Incentive Liability CustomerIncentiveLiability	52602000	usd
CY2022Q3	cdlx	Customer Incentive Liability CustomerIncentiveLiability	48353000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3280000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3004000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6028000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6088000	usd
CY2021Q4	cdlx	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	182470000	usd
CY2022Q3	cdlx	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	118151000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	327350000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	254911000	usd
CY2021Q4	us-gaap	Senior Notes SeniorNotes	184398000	usd
CY2022Q3	us-gaap	Senior Notes SeniorNotes	225678000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6801000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5135000	usd
CY2021Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	173000	usd
CY2022Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	58000	usd
CY2021Q4	cdlx	Contingent Consideration Liability Long Term ContingentConsiderationLiabilityLongTerm	49825000	usd
CY2022Q3	cdlx	Contingent Consideration Liability Long Term ContingentConsiderationLiabilityLongTerm	0	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4550000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	21000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	573097000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	485803000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1212823000	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1169213000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	486000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	9578000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-522618000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-598291000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	690700000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	580509000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1263797000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1066312000	usd
CY2021Q3	us-gaap	Revenues Revenues	64984000	usd
CY2022Q3	us-gaap	Revenues Revenues	72706000	usd
	us-gaap	Revenues Revenues	177067000	usd
	us-gaap	Revenues Revenues	216039000	usd
CY2021Q3	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	34090000	usd
CY2022Q3	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	37563000	usd
	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	93814000	usd
	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	112996000	usd
CY2021Q3	cdlx	Delivery Costs DeliveryCosts	6390000	usd
CY2022Q3	cdlx	Delivery Costs DeliveryCosts	9125000	usd
	cdlx	Delivery Costs DeliveryCosts	16076000	usd
	cdlx	Delivery Costs DeliveryCosts	23820000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16733000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18289000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	46998000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	57920000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11141000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13762000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26293000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39634000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20073000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19972000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	49136000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	61381000	usd
CY2021Q3	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	1714000	usd
CY2022Q3	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	-1867000	usd
	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	22926000	usd
	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	-4269000	usd
CY2021Q3	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	6261000	usd
CY2022Q3	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-46126000	usd
	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	7741000	usd
	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-114144000	usd
CY2021Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	83149000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8375000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10468000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20273000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	30695000	usd
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	104777000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	61186000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	283257000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	291182000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-39793000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	11520000	usd
	us-gaap	Restructuring Charges RestructuringCharges	800000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-106190000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-75143000	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3193000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-580000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9316000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2406000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1543000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4673000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1224000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10882000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4736000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5253000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10540000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13288000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44529000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6267000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-116730000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-88431000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1446000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-44529000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	6267000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-116730000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-86985000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44529000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6267000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-116730000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-86985000	usd
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.35
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.67
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.60
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.35
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.60
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33101000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32950000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31802000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33455000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33101000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33269000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31802000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33455000	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-44529000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	6267000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-116730000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-86985000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1267000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3998000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	807000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	9092000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43262000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10265000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-115923000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-77893000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	690700000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	417000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33950000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1503000	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	40000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9092000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-86985000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	580509000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	564157000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6087000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3998000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	6267000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	580509000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	157192000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1930000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37952000	usd
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3850000	shares
CY2021Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	484049000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	117349000	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	3593000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1637000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	807000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-116730000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	688620000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	714392000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	474000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17016000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1267000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-44529000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	688620000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-116730000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-86985000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1440000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	949000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20273000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30695000	usd
	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	701000	usd
	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	1192000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7078000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3770000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	4230000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	37415000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	32194000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	83149000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	7741000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-114144000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1275000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-10524000	usd
	cdlx	Contract With Customer Asset Deferred Implementation Costs ContractWithCustomerAssetDeferredImplementationCosts	2343000	usd
	cdlx	Contract With Customer Asset Deferred Implementation Costs ContractWithCustomerAssetDeferredImplementationCosts	0	usd
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	0	usd
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-1446000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	757000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15082000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1296000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	456000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	42000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	111000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2626000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5814000	usd
	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-2171000	usd
	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-5836000	usd
	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	3534000	usd
	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-4248000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37968000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40803000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2145000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1090000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	68000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	73000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	6937000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	9170000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	494131000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2274000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-503281000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12607000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	24000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	486163000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	397000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	190000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	40000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	200000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	181000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	485773000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-39808000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-393000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1756000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-55869000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-94974000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293349000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233562000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	237480000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	138588000	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	237372000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	138514000	usd
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	108000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	74000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	237480000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	138588000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2308000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2358000	usd
	cdlx	Noncash Or Part Noncash Acquisition Accrued Consideration NoncashOrPartNoncashAcquisitionAccruedConsideration	117354000	usd
	cdlx	Noncash Or Part Noncash Acquisition Accrued Consideration NoncashOrPartNoncashAcquisitionAccruedConsideration	0	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	11937000	usd
CY2021Q3	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	1016000	usd
CY2022Q3	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	0	usd
	us-gaap	Deferred Policy Acquisition Costs Amortization Expense Excluding Accrued Interest DeferredPolicyAcquisitionCostsAmortizationExpenseExcludingAccruedInterest	462000	usd
	us-gaap	Deferred Policy Acquisition Costs Amortization Expense Excluding Accrued Interest DeferredPolicyAcquisitionCostsAmortizationExpenseExcludingAccruedInterest	0	usd
CY2022Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	40000000	usd
CY2022Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1405655	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	28.44
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Significant items subject to such estimates and assumptions include revenue recognition, internal-use software development costs, stock-based compensation, allowance for doubtful accounts, valuation of acquired intangible assets, valuation of contingent consideration for Bridg, goodwill impairment, income tax including valuation allowance and contingencies. We base our estimates on historical experience and on assumptions that we believe are reasonable. Changes in facts or circumstances may cause us to change our assumptions and estimates in future periods and it is possible that actual results could differ from our current or revised future estimates.</span></div>
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10196000	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9276000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	86000	usd
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	57000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	10282000	usd
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	9333000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6028000	usd
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6088000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7200000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6801000	usd
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5135000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	36000	usd
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	37000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	50000	usd
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	21000	usd
CY2021Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	12915000	usd
CY2021Q3	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	11281000	usd
CY2021Q3	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	1700000	usd
	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	22900000	usd
CY2022Q3	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	-1900000	usd
	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	-4300000	usd
CY2022Q3	cdlx	Business Combination Proforma Information Revenue Of Acquiree Since Acquisition Date Actual Percent BusinessCombinationProformaInformationRevenueOfAcquireeSinceAcquisitionDateActualPercent	0.03
CY2021Q4	us-gaap	Goodwill Goodwill	742516000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5062000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	665813000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	154500000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	41272000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	113228000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	144700000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19712000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	124988000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	7172000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	28695000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	27976000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	27336000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	17596000	usd
CY2022Q3	cdlx	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	4453000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	113228000	usd
CY2021Q3	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	33400000	usd
CY2022Q3	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	37700000	usd
	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	83000000	usd
	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	100300000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	62075000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67285000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	172068000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	200538000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	78000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	53000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1800000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1363000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	23300000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	16300000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2020Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000	usd
CY2020Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2020Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	222700000	usd
CY2020Q3	cdlx	Adjustments To Additional Paid In Capital Issuance Of Capped Calls AdjustmentsToAdditionalPaidInCapitalIssuanceOfCappedCalls	26500000	usd
CY2020Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	10000	numberofdays
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.98
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	11.7457
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	85140
CY2020Q3	cdlx	Debt Instrument Convertible Redemption Period Days Before Maturity Date DebtInstrumentConvertibleRedemptionPeriodDaysBeforeMaturityDate	P36D
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2022Q3	cdlx	Debt Instrument Convertible Threshold Principal Outstanding Amount For Partial Redemption DebtInstrumentConvertibleThresholdPrincipalOutstandingAmountForPartialRedemption	75000000	usd
CY2020Q3	cdlx	Debt Instrument Required Compliance Period Period After Written Notice DebtInstrumentRequiredCompliancePeriodPeriodAfterWrittenNotice	P60D
CY2020Q3	cdlx	Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance	0.25
CY2020Q3	cdlx	Debt Instrument Convertible Redemption Requirement Amount Of Other Debt Called Due DebtInstrumentConvertibleRedemptionRequirementAmountOfOtherDebtCalledDue	35000000	usd
CY2020Q3	cdlx	Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance	0.25
	cdlx	Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance	0.25
	cdlx	Debt Instrument Convertible Covenant Noncompliance Period Of Additional Interest DebtInstrumentConvertibleCovenantNoncompliancePeriodOfAdditionalInterest	P365D
	cdlx	Debt Instrument Convertible Liability Component Discount Rate DebtInstrumentConvertibleLiabilityComponentDiscountRate	0.0650
CY2021Q4	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	53096000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	1680000	usd
CY2021	cdlx	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustment1 AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustment1	51416000	usd
CY2021Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	575000	usd
CY2022Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	575000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1725000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1725000	usd
CY2021Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2398000	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7078000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2021Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	222000	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	365000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	644000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1095000	usd
CY2021Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3195000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	940000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	9447000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	2820000	usd
CY2021Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0556
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0164
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0164
CY2020Q3	cdlx	Adjustments To Additional Paid In Capital Issuance Of Capped Calls AdjustmentsToAdditionalPaidInCapitalIssuanceOfCappedCalls	26500000	usd
CY2020Q3	us-gaap	Option Indexed To Issuers Equity Strike Price1 OptionIndexedToIssuersEquityStrikePrice1	85.14
CY2020Q3	cdlx	Option Indexed To Issuers Equity Cap Price OptionIndexedToIssuersEquityCapPrice	128.51
CY2022Q3	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	60000000	usd
CY2022Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	usd
CY2022Q3	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	60000000	usd
CY2022Q3	cdlx	Line Of Credit Facility Maximum Borrowing Capacity Percentage Of Eligible Accounts Receivable LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleAccountsReceivable	0.85
CY2022Q3	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	60000000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2033227	shares
CY2022Q3	cdlx	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Annual Percentage Increase ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedAnnualPercentageIncrease	0.05
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1676682	shares
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16830000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5767000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	37415000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32194000	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	500000	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1000000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	9.40
	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	9.40
	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	9.40
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4490000	shares
CY2021Q2	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	232401000	usd
CY2022Q2	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	164277000	usd
CY2020Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	0	usd
CY2021Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	232295000	usd
CY2021Q3	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	0	usd
CY2022Q3	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	0	usd
	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	230921000	usd
	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	0	usd
CY2021Q3	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	6261000	usd
CY2022Q3	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-46126000	usd
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	7741000	usd
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-114144000	usd
CY2021Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	238662000	usd
CY2022Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	118151000	usd
CY2021Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	238662000	usd
CY2022Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	118151000	usd
	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	9.40
CY2021Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	2173000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	0	usd
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	3785000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	0	usd
CY2021Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-731000	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	0	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-2343000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	0	usd
CY2021Q3	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	1442000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	0	usd
CY2021Q3	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	1442000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	0	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-44529000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	6267000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-116730000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-86985000	usd
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33101000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32950000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31802000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33455000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33101000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33269000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31802000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33455000	shares
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.35
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.60
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2021Q3	cdlx	Adjusted Contribution AdjustedContribution	31625000	usd
CY2022Q3	cdlx	Adjusted Contribution AdjustedContribution	35143000	usd
	cdlx	Adjusted Contribution AdjustedContribution	85596000	usd
	cdlx	Adjusted Contribution AdjustedContribution	103043000	usd
CY2021Q3	cdlx	Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts	33359000	usd
CY2022Q3	cdlx	Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts	37563000	usd
	cdlx	Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts	91471000	usd
	cdlx	Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts	112996000	usd
CY2021Q3	us-gaap	Revenues Revenues	64984000	usd
CY2022Q3	us-gaap	Revenues Revenues	72706000	usd
	us-gaap	Revenues Revenues	177067000	usd
	us-gaap	Revenues Revenues	216039000	usd
CY2021Q3	cdlx	Adjusted Contribution AdjustedContribution	31625000	usd
CY2022Q3	cdlx	Adjusted Contribution AdjustedContribution	35143000	usd
	cdlx	Adjusted Contribution AdjustedContribution	85596000	usd
	cdlx	Adjusted Contribution AdjustedContribution	103043000	usd
CY2021Q3	cdlx	Contract With Customer Asset Deferred Implementation Costs Amortization ContractWithCustomerAssetDeferredImplementationCostsAmortization	731000	usd
CY2022Q3	cdlx	Contract With Customer Asset Deferred Implementation Costs Amortization ContractWithCustomerAssetDeferredImplementationCostsAmortization	0	usd
	cdlx	Contract With Customer Asset Deferred Implementation Costs Amortization ContractWithCustomerAssetDeferredImplementationCostsAmortization	2343000	usd
	cdlx	Contract With Customer Asset Deferred Implementation Costs Amortization ContractWithCustomerAssetDeferredImplementationCostsAmortization	0	usd
CY2021Q3	cdlx	Delivery Costs DeliveryCosts	6390000	usd
CY2022Q3	cdlx	Delivery Costs DeliveryCosts	9125000	usd
	cdlx	Delivery Costs DeliveryCosts	16076000	usd
	cdlx	Delivery Costs DeliveryCosts	23820000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16733000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18289000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	46998000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	57920000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11141000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13762000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26293000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39634000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20073000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19972000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	49136000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	61381000	usd
CY2021Q3	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	1714000	usd
CY2022Q3	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	-1867000	usd
	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	22926000	usd
	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	-4269000	usd
CY2021Q3	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	6261000	usd
CY2022Q3	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-46126000	usd
	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	7741000	usd
	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-114144000	usd
CY2021Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	83149000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8375000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10468000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20273000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	30695000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4736000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5253000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10540000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13288000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44529000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6267000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-116730000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-88431000	usd
CY2021Q3	us-gaap	Revenues Revenues	64984000	usd
CY2022Q3	us-gaap	Revenues Revenues	72706000	usd
	us-gaap	Revenues Revenues	177067000	usd
	us-gaap	Revenues Revenues	216039000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11273000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7103000	usd

Files In Submission

Name	View Source	Status
0001666071-22-000134-index-headers.html	Edgar Link	pending
0001666071-22-000134-index.html	Edgar Link	pending
0001666071-22-000134.txt	Edgar Link	pending
0001666071-22-000134-xbrl.zip	Edgar Link	pending
cdlx-20220930.htm	Edgar Link	pending
cdlx-20220930.xsd	Edgar Link	pending
cdlx-20220930_g1.jpg	Edgar Link	pending
cdlx_form10-qx2022q3xex101.htm	Edgar Link	pending
cdlx_form10-qx2022q3xex102.htm	Edgar Link	pending
cdlx_form10-qx2022q3xex103.htm	Edgar Link	pending
cdlx_form10-qx2022q3xex104.htm	Edgar Link	pending
cdlx_form10-qx2022q3xex311.htm	Edgar Link	pending
cdlx_form10-qx2022q3xex312.htm	Edgar Link	pending
cdlx_form10-qx2022q3xex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
cdlx-20220930_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cdlx-20220930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cdlx-20220930_lab.xml	Edgar Link	unprocessable
cdlx-20220930_def.xml	Edgar Link	unprocessable
cdlx-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDLX
Cardlytics, Inc. Stock $cdlx

2022 Q4 Form 10-Q Financial Statement

#000166607122000134 Filed on November 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX Cardlytics, Inc. Stock $cdlx

2022 Q4 Form 10-Q Financial Statement

#000166607122000134 Filed on November 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX
Cardlytics, Inc. Stock $cdlx